Kidron is a global, next-generation FemTech venture capital fund investing in innovative medical technologies for women’s health. Though accounting for half of the world’s population, women have historically been, and still are, underserved by medical research, development and practice. Kidron invests in early-stage, ground-breaking FemTech startups, with enormous potential to create a substantial impact on women’s health while generating significant ROI for investors. Technologies are sourced internationally from companies developing break-through solutions in digital health, clinical informatics as well as pharma and biotech. Kidron’s indications of interest include brain health, heart disease, gynecology and reproductive health, bone health, oncology and autoimmune diseases. The fund will invest in a handful of carefully selected promising companies. Kidron’s world-class team includes venture capital, business, healthtech and finance industry experts and the first strategic investor has already engaged. The fund is led by Managing Partners Maria Gajda Horowitz and Gilad Peleg. For more information: http://kidron-capital.com/